Recalls / Class III
Class IIID-0023-2026
Product
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
- Affected lot / code info
- Lot #: 25104595A, Expiry: 27DEC2025.
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Exp Date
Recalling firm
- Firm
- STAQ Pharma, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 14135 E 42nd Ave Ste 50, Denver, Colorado 80239-5214
Distribution
- Distribution pattern
- Nationwide in the U.S.
Timeline
- Recall initiated
- 2025-10-09
- FDA classified
- 2025-10-15
- Posted by FDA
- 2025-10-22
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0023-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.